244 related articles for article (PubMed ID: 32194550)
1. Myeloid Cells Enriched for a Dendritic Cell Population From People Living With HIV Have Altered Gene Expression Not Restored by Antiretroviral Therapy.
Murray SM; Zhang Y; Douek DC; Sekaly RP
Front Immunol; 2020; 11():261. PubMed ID: 32194550
[TBL] [Abstract][Full Text] [Related]
2. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
Iannetta M; Savinelli S; Rossi R; Mascia C; Marocco R; Vita S; Zuccalà P; Zingaropoli MA; Mengoni F; Massetti AP; Falciano M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V; Lichtner M
Immunobiology; 2019 Mar; 224(2):231-241. PubMed ID: 30522891
[TBL] [Abstract][Full Text] [Related]
3. Differential restoration of myeloid and plasmacytoid dendritic cells in HIV-1-infected children after treatment with highly active antiretroviral therapy.
Zhang Z; Fu J; Zhao Q; He Y; Jin L; Zhang H; Yao J; Zhang L; Wang FS
J Immunol; 2006 May; 176(9):5644-51. PubMed ID: 16622034
[TBL] [Abstract][Full Text] [Related]
4. Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection.
Almeida M; Cordero M; Almeida J; Orfao A
Curr HIV Res; 2007 May; 5(3):325-36. PubMed ID: 17504174
[TBL] [Abstract][Full Text] [Related]
5. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
Dillon SM; Friedlander LJ; Rogers LM; Meditz AL; Folkvord JM; Connick E; McCarter MD; Wilson CC
J Virol; 2011 Jan; 85(1):397-409. PubMed ID: 20962079
[TBL] [Abstract][Full Text] [Related]
6. The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy.
Fernandez S; Stone SF; Price P; French MA
Clin Immunol; 2008 Aug; 128(2):228-37. PubMed ID: 18511344
[TBL] [Abstract][Full Text] [Related]
7. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.
Chehimi J; Campbell DE; Azzoni L; Bacheller D; Papasavvas E; Jerandi G; Mounzer K; Kostman J; Trinchieri G; Montaner LJ
J Immunol; 2002 May; 168(9):4796-801. PubMed ID: 11971031
[TBL] [Abstract][Full Text] [Related]
8. The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.
Kumar NA; Cheong K; Powell DR; da Fonseca Pereira C; Anderson J; Evans VA; Lewin SR; Cameron PU
Retrovirology; 2015 Sep; 12():76. PubMed ID: 26362311
[TBL] [Abstract][Full Text] [Related]
9. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
Killian MS; Fujimura SH; Hecht FM; Levy JA
AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
[TBL] [Abstract][Full Text] [Related]
10. Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy.
Schmidt B; Fujimura SH; Martin JN; Levy JA
J Clin Immunol; 2006 Jan; 26(1):55-64. PubMed ID: 16418803
[TBL] [Abstract][Full Text] [Related]
11. Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells.
Yonkers NL; Rodriguez B; Asaad R; Lederman MM; Anthony DD
PLoS One; 2011; 6(9):e23884. PubMed ID: 21912648
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy.
Benlahrech A; Yasmin A; Westrop SJ; Coleman A; Herasimtschuk A; Page E; Kelleher P; Gotch F; Imami N; Patterson S
Clin Exp Immunol; 2012 Nov; 170(2):212-21. PubMed ID: 23039892
[TBL] [Abstract][Full Text] [Related]
13. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
14. Low CD1c + myeloid dendritic cell counts correlated with a high risk of rapid disease progression during early HIV-1 infection.
Diao Y; Geng W; Fan X; Cui H; Sun H; Jiang Y; Wang Y; Sun A; Shang H
BMC Infect Dis; 2015 Aug; 15():342. PubMed ID: 26286082
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients.
Márquez-Coello M; Montes de Oca Arjona M; Martín-Aspas A; Guerrero Sánchez F; Fernández-Gutiérrez Del Álamo C; Girón-González JA
Sci Rep; 2019 Aug; 9(1):11654. PubMed ID: 31406185
[TBL] [Abstract][Full Text] [Related]
16. Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.
Miller EA; Spadaccia MR; OʼBrien MP; Rolnitzky L; Sabado R; Manches O; Frleta D; Bhardwaj N
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):535-44. PubMed ID: 22902724
[TBL] [Abstract][Full Text] [Related]
17. Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4
Kumar NA; van der Sluis RM; Mota T; Pascoe R; Evans VA; Lewin SR; Cameron PU
J Immunol; 2018 Sep; 201(5):1468-1477. PubMed ID: 30030324
[TBL] [Abstract][Full Text] [Related]
18. B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection.
Wang X; Zhang Z; Zhang S; Fu J; Yao J; Jiao Y; Wu H; Wang FS
Eur J Immunol; 2008 Nov; 38(11):3226-36. PubMed ID: 18924219
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
d'Ettorre G; Forcina G; Andreotti M; Sarmati L; Palmisano L; Andreoni M; Vella S; Mastroianni CM; Vullo V
Clin Exp Immunol; 2004 Feb; 135(2):280-5. PubMed ID: 14738457
[TBL] [Abstract][Full Text] [Related]
20. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
